Naturhouse Health S.A.U. | Small-cap | Consumer Defensive

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2020

Income Metrics

Revenue 12.0M
Gross Profit 8.6M 72.07%
Operating Income 4.4M 36.53%
Net Income 1.9M 16.01%

Balance Sheet Metrics

Total Assets 42.6M
Total Liabilities 10.9M
Shareholders Equity 31.7M
Debt to Equity 0.34

Cash Flow Metrics

Revenue & Profitability Trend

Naturhouse Health Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i49.4M50.4M52.4M57.6M55.1M
Cost of Goods Sold i14.0M13.7M14.9M16.3M15.9M
Gross Profit i35.5M36.7M37.5M41.3M39.2M
Gross Margin % i71.8%72.8%71.5%71.6%71.2%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i3.4M2.7M3.5M3.9M2.9M
Other Operating Expenses i6.7M6.0M7.9M6.6M6.7M
Total Operating Expenses i10.1M8.7M11.4M10.6M9.6M
Operating Income i13.1M16.3M12.8M17.5M14.4M
Operating Margin % i26.6%32.3%24.5%30.5%26.1%
Non-Operating Items
Interest Income i542.0K43.0K111.0K361.0K24.0K
Interest Expense i139.0K107.0K206.0K100.0K185.0K
Other Non-Operating Income-----
Pre-tax Income i13.5M15.4M13.1M18.2M13.5M
Income Tax i3.7M4.2M3.5M4.9M4.1M
Effective Tax Rate % i27.2%27.0%26.6%26.7%30.5%
Net Income i9.9M11.2M9.6M13.4M9.4M
Net Margin % i20.0%22.3%18.4%23.2%17.0%
Key Metrics
EBITDA i16.1M18.3M15.6M21.0M18.1M
EPS (Basic) i-€0.19€0.16€0.22€0.16
EPS (Diluted) i-€0.19€0.16€0.22€0.16
Basic Shares Outstanding i-59949480599494805994948059967740
Diluted Shares Outstanding i-59949480599494805994948059967740

Income Statement Trend

Naturhouse Health Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i20.7M24.4M12.1M27.2M21.6M
Short-term Investments i991.0K2.7M2.7M--
Accounts Receivable i2.0M2.5M2.4M2.7M4.0M
Inventory i3.4M2.8M2.7M2.6M3.3M
Other Current Assets---779.0K531.0K
Total Current Assets i28.2M34.4M27.1M37.3M33.4M
Non-Current Assets
Property, Plant & Equipment i00000
Goodwill i371.0K444.0K609.0K753.0K972.0K
Intangible Assets i371.0K444.0K609.0K753.0K972.0K
Long-term Investments-----
Other Non-Current Assets-----
Total Non-Current Assets i14.4M14.5M15.8M11.7M9.1M
Total Assets i42.6M48.8M42.8M49.0M42.6M
Liabilities
Current Liabilities
Accounts Payable i3.6M4.1M3.4M3.2M5.7M
Short-term Debt i880.0K1.4M1.2M894.0K1.2M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i6.5M12.8M8.4M8.1M9.7M
Non-Current Liabilities
Long-term Debt i2.2M1.8M2.1M1.3M2.5M
Deferred Tax Liabilities i244.0K275.0K306.0K294.0K154.0K
Other Non-Current Liabilities-----
Total Non-Current Liabilities i4.4M5.5M6.6M4.9M6.8M
Total Liabilities i10.9M18.2M15.0M12.9M16.5M
Equity
Common Stock i3.0M3.0M3.0M3.0M3.0M
Retained Earnings i9.9M11.3M9.6M13.4M9.4M
Treasury Stock i142.0K142.0K142.0K142.0K142.0K
Other Equity-----
Total Shareholders Equity i31.7M30.6M27.9M36.1M26.0M
Key Metrics
Total Debt i3.0M3.2M3.3M2.2M3.7M
Working Capital i21.7M21.6M18.7M29.2M23.7M

Balance Sheet Composition

Naturhouse Health Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i13.5M15.4M13.1M18.2M13.5M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-350.0K-417.0K-3.4M1.8M764.0K
Operating Cash Flow i14.2M15.6M9.8M19.8M14.4M
Investing Activities
Capital Expenditures i189.0K49.0K0--
Acquisitions i-0-4.4M-3.5M0
Investment Purchases i00-692.0K-703.0K0
Investment Sales i1.0M62.0K826.0K0132.0K
Investing Cash Flow i1.2M111.0K-4.3M-4.2M132.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-12.0M-6.0M-18.0M-3.6M-
Debt Issuance i-----
Debt Repayment i-4.1M-1.7M--2.7M-3.4M
Financing Cash Flow i-16.1M-7.7M-18.0M-6.3M-3.4M
Free Cash Flow i11.2M20.4M6.1M16.1M14.4M
Net Change in Cash i-666.0K8.0M-12.4M9.3M11.2M

Cash Flow Trend

Naturhouse Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 11.88
Forward P/E 9.05
Price to Book 3.60
Price to Sales 2.30
PEG Ratio 9.05

Profitability Ratios

Profit Margin 19.96%
Operating Margin 23.24%
Return on Equity 31.65%
Return on Assets 17.96%

Financial Health

Current Ratio 4.36
Debt to Equity 13.48
Beta 0.59

Per Share Data

EPS (TTM) €0.16
Book Value per Share €0.53
Revenue per Share €0.82

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
nth113.9M11.883.6031.65%19.96%13.48
Ebro Foods, S.A 2.7B13.731.249.72%6.33%25.71
Deoleo S.A 90.0M19.980.43-12.07%-3.00%33.16
Coca-Cola 35.4B23.204.4117.93%7.35%141.24
Puig Brands S.A 2.5B27.293.8348.50%9.12%71.01
Proper Education 1.5B27.9049.04202.53%13.95%0.25

Financial data is updated regularly. All figures are in the company's reporting currency.